Continuous glucose monitor

Optomec Reports $2 Million in Orders from Leading Media and Technology OEM

Retrieved on: 
Monday, November 1, 2021
Other Manufacturing, Hardware, Electronic Design Automation, Consumer Electronics, Technology, Semiconductor, Manufacturing, Mobile, Wireless, Georgia Tech, NASA, University, Virtual reality, Digital product design, Industry, AR, Printed electronics, 3D printing, Display device, E-textiles, 3D, Electronics, Software, University of Cambridge, View, CGMS-A, Biomedical engineering, LENS, Samsung, Ernest K. Warburton (US Air Force), Inc., Â, Continuous glucose monitor, Raytheon Technologies, Brain–computer interface, Multimedia, Wearable, GE, Lockheed, Solution, Lite-On, Additive, United States Air Force, Printing, Integrated circuit packaging, Sandia National Laboratories

Optomec Inc., the leading supplier of 3D Additive Electronics manufacturing solutions today announced the receipt of orders totaling approximately $2 Million from a premier supplier of digital connectivity solutions.

Key Points: 
  • Optomec Inc., the leading supplier of 3D Additive Electronics manufacturing solutions today announced the receipt of orders totaling approximately $2 Million from a premier supplier of digital connectivity solutions.
  • The recent orders include the delivery of three (3) Aerosol Jet 3D Electronics Printers, together with related Software and Digital Products, plus professional services to support their application development.
  • The customer is leveraging Optomecs patented Aerosol Jet process for the development and ultimate production of a variety of next generation Wearable devices.
  • LENS is a registered trademark of Sandia National Labs; Aerosol Jet is a registered trademark of Optomec, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20211101005906/en/

Global Diabetes Devices (BGM Devices/Insulin Delivery) Markets Report 2021: Market Size is Expected to Reach $44.6 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 11, 2021
Health, Diabetes, Incidence, Blood, USD, Obesity, CAGR, CGM, Diabetes, Public health, National Center for Biotechnology Information, Adoption, FDA, Blood glucose monitoring, Hospital, BGM, Medical tourism, Insulin, Harvard T.H. Chan School of Public Health, Awareness, Market share, Solution, National Center for Health Research, Continuous glucose monitor, Government, Glucose meter, NCBI, Medical device, Online shopping

The "Global Diabetes Devices Market Size, Share & Trends Analysis Report by Type (BGM Devices, Insulin Delivery Devices), by Distribution Channel, by End-use (Hospitals, Homecare), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Diabetes Devices Market Size, Share & Trends Analysis Report by Type (BGM Devices, Insulin Delivery Devices), by Distribution Channel, by End-use (Hospitals, Homecare), by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6%
    The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches.
  • Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.
  • They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms.

Innovation Zed Announce Non-Invasive Continuous Glucose Monitoring Project and Appointment of a New Researcher

Retrieved on: 
Monday, October 11, 2021
UCD, Pain, MDI, IRC, CGM, Diabetes, GLOBE, Innovation, University College Dublin, Health, Irish Research Council, Center, Quality of life, Skin, Biomedicine, Continuous glucose monitor, CEO, Infection, Partnership, Glucose meter, Research, Biomedical engineering, Medical device

Innovation Zed has collaborated with the Irish Research Council (IRC) and University College Dublin (UCD) in advancing their research into non-invasive Continuous Glucose Monitoring (CGM) systems.

Key Points: 
  • Innovation Zed has collaborated with the Irish Research Council (IRC) and University College Dublin (UCD) in advancing their research into non-invasive Continuous Glucose Monitoring (CGM) systems.
  • "We are delighted to advance our research into a non-invasive CGM system," said Dr Dean Minnock, CEO, Innovation Zed.
  • "I am delighted to be involved in this project and to be working with Innovation Zed on this fascinating project," said Dr Wu.
  • "This non-invasive glucometer project is the latest addition to several exciting projects here at Innovation Zed," said Dr Minnock.

Telehealth & Home Healthcare Solutions Witnessed Exponential Uptake in the Last Few Years - Arizton

Retrieved on: 
Thursday, October 7, 2021
Well, Cloud, Lists of countries and territories, Center, AI, USD, Health, McKesson Corporation, ML, CAGR, COVID-19, Medtronic, AMD, MHealth, Centers for Medicare & Medicaid Services, IPhone, Traction, Growth, UnitedHealth Group, Population, Fitbit, BD, Adoption, Telehealth, Hospital, CMS, Medicare, Vaccine, IOS, Apple, Cerner, Patient, Sale, Abbott, Research, Technology, Continuous glucose monitor, Ecosystem, Epic Systems, Pharmaceutical industry, Retail

The UK, France, Germany, Italy, Spain, and the Netherlands in Europe are contributing to the highest growth in the telehealth market.

Key Points: 
  • The UK, France, Germany, Italy, Spain, and the Netherlands in Europe are contributing to the highest growth in the telehealth market.
  • With the launch of many advanced and innovative medical devices every year, people are opting for home healthcare services.
  • Recognizing the significant benefits of telehealth services, the Centers for Medicare & Medicaid Services (CMS) have expanded the reimbursement options for telehealth services.
  • Wearable medical devices and enhanced telehealth services is likely to have a positive impact on the growth of the US telehealth market in the coming years.

Telehealth & Home Healthcare Solutions Witnessed Exponential Uptake in the Last Few Years - Arizton

Retrieved on: 
Thursday, October 7, 2021
Well, Cloud, Lists of countries and territories, Center, AI, USD, Health, McKesson Corporation, ML, CAGR, COVID-19, Medtronic, AMD, MHealth, Centers for Medicare & Medicaid Services, IPhone, Traction, Growth, UnitedHealth Group, Population, Fitbit, BD, Adoption, Telehealth, Hospital, CMS, Medicare, Vaccine, IOS, Apple, Cerner, Patient, Sale, Abbott, Research, Technology, Continuous glucose monitor, Ecosystem, Epic Systems, Pharmaceutical industry, Retail

The UK, France, Germany, Italy, Spain, and the Netherlands in Europe are contributing to the highest growth in the telehealth market.

Key Points: 
  • The UK, France, Germany, Italy, Spain, and the Netherlands in Europe are contributing to the highest growth in the telehealth market.
  • With the launch of many advanced and innovative medical devices every year, people are opting for home healthcare services.
  • Recognizing the significant benefits of telehealth services, the Centers for Medicare & Medicaid Services (CMS) have expanded the reimbursement options for telehealth services.
  • Wearable medical devices and enhanced telehealth services is likely to have a positive impact on the growth of the US telehealth market in the coming years.

A new analysis that supports the effect of the diabetes vaccine Diamyd® will be presented at a scientific conference on 13 October

Retrieved on: 
Thursday, September 23, 2021
ISPAD, Clinical trial, Diamyd Medical, International Society for Pediatric and Adolescent Diabetes, Hyperglycemia, GAD65, Society, Hannelius, ASHG, Diabetes, Patient, Type 1, Glycated hemoglobin, Eli Lilly and Company, Pediatrics, Continuous glucose monitor, International Society of Sculptors, Painters and Gravers, CEO, Blood, Meta-analysis, Company, Adolescence, Congress, Uppsala University Hospital, Human genetics, CGM, Hypoglycemia, Insulin, IIB, HLA, Nasdaq, EASD, Regeneration, Pharmaceutical industry

The analysis is based on data from Continuous Glucose Montitoring (CGM) and will be presented by Professor Johnny Ludvigsson, Principal Investigator of the clinical trial DIAGNODE-2.

Key Points: 
  • The analysis is based on data from Continuous Glucose Montitoring (CGM) and will be presented by Professor Johnny Ludvigsson, Principal Investigator of the clinical trial DIAGNODE-2.
  • Complete results will be submitted for publication in a scientific journal later this year.
  • The diabetes vaccine Diamyd is an antigen-specific immunotherapy for the preservation of endogenous insulin production.
  • A vaccine manufacturing facility is being set up in Ume for the manufacture of recombinant GAD65, the active ingredient in the therapeutic diabetes vaccine Diamyd.

A new analysis that supports the effect of the diabetes vaccine Diamyd® will be presented at a scientific conference on 13 October

Retrieved on: 
Thursday, September 23, 2021
ISPAD, Clinical trial, Diamyd Medical, International Society for Pediatric and Adolescent Diabetes, Hyperglycemia, GAD65, Society, Hannelius, ASHG, Diabetes, Patient, Type 1, Glycated hemoglobin, Eli Lilly and Company, Pediatrics, Continuous glucose monitor, International Society of Sculptors, Painters and Gravers, CEO, Blood, Meta-analysis, Company, Adolescence, Congress, Uppsala University Hospital, Human genetics, CGM, Hypoglycemia, Insulin, IIB, HLA, Nasdaq, EASD, Regeneration, Pharmaceutical industry

The analysis is based on data from Continuous Glucose Montitoring (CGM) and will be presented by Professor Johnny Ludvigsson, Principal Investigator of the clinical trial DIAGNODE-2.

Key Points: 
  • The analysis is based on data from Continuous Glucose Montitoring (CGM) and will be presented by Professor Johnny Ludvigsson, Principal Investigator of the clinical trial DIAGNODE-2.
  • Complete results will be submitted for publication in a scientific journal later this year.
  • The diabetes vaccine Diamyd is an antigen-specific immunotherapy for the preservation of endogenous insulin production.
  • A vaccine manufacturing facility is being set up in Ume for the manufacture of recombinant GAD65, the active ingredient in the therapeutic diabetes vaccine Diamyd.

United States Continuous Glucose Monitoring (CGM) Market Report 2021: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast 2019-2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 8, 2021
Diabetes, Health, Medical Supplies

The "United States Continuous Glucose Monitoring (CGM) Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Continuous Glucose Monitoring (CGM) Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • "United States Continuous Glucose Monitoring (CGM) Market Report" is based on an inclusive study of the entire United States Continuous Glucose Monitoring (CGM) market.
  • The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States Continuous Glucose Monitoring (CGM) market.
  • The report delivers a clear understanding of the up-to-date and future growths of the United States Continuous Glucose Monitoring (CGM) market.

Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management

Retrieved on: 
Monday, August 2, 2021
IOS, Operating systems, ITunes, Smartphones, Mobile software, Software, Diabetes, Diabetes management, App store, Health, IPhone, App store

"The FreeStyle Libre 2 iOS app streamlines how people manage their diabetes on their iPhones empowering users with the information they need 24/7 while improving their health on the go."

Key Points: 
  • "The FreeStyle Libre 2 iOS app streamlines how people manage their diabetes on their iPhones empowering users with the information they need 24/7 while improving their health on the go."
  • According to a recent Gallup poll, 1 in 5 Americans currently tracks health statistics using a mobile app.8Free to download on the iOS App Store soon, the FreeStyle Libre 2 app will offer personalized, up-to-the-minute glucose data for people with diabetes who are using FreeStyle Libre 2 glucose sensors.
  • By scanning the sensor with the FreeStyle Libre 2 app, users will get their current glucose reading and trend arrow which can help them determine how food, exercise and other lifestyle factors impact diabetes management.
  • The FreeStyle Libre 2 iOS app will be available soon in the U.S. to download on the App Store.

Global Blood Glucose Monitoring Market Report 2021-2025 - Market is Expected to Increase at a CAGR of 13.8% - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021
Diabetes, Health, Medical devices, Medicine, Branches of biology, Diabetes, Clinical medicine, Medical monitoring, Continuous glucose monitor, Blood sugar level, Glucose, Blood glucose monitoring, Diabetes management

The "Diabetes Management: Blood Glucose Monitoring Devices Market (2021)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Diabetes Management: Blood Glucose Monitoring Devices Market (2021)" report has been added to ResearchAndMarkets.com's offering.
  • The burgeoning global blood glucose monitoring market is expected to increase at a healthy CAGR of 13.8%, from nearly $9.1bn in 2019, $9.8bn in 2020, to an estimated $19.7bn in 2025.
  • The blood glucose monitoring devices market includes: conventional handheld blood glucose meters (BGMs) that require frequent fingersticks, and new, sensor-based continuous glucose monitoring systems (CGMs) typically worn the upper arm or abdomen that conveniently monitor blood glucose 24/7, as well as lucrative supplies and software/accessories.
  • This comprehensive medical market and technology report provides:
    In-depth market and competitive analyses (market drivers/limiters, 6-year market forecasts by segment and region, 2019 and 2020 global/regional market share)